Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Papua and New Guinea Medical Journal
|
November 11, 2010
Is a 'convenience' sample useful for estimating immunization coverage in a small population?
Jean E Weir, Carrie Jones
ACS Chemical Biology
|
January 25, 2007
Preclinical drug discovery research and training at Vanderbilt
Craig W Lindsley, David Weaver, Carrie Jones, et al.
The International Journal on Drug Policy
|
May 31, 2021
Appreciating contributions more than celebrating resilience: Reflections on the disclosure of substance use in Appalachia
Lindy Clapp, Samuel Conner, David Fonseca, et al.
Applied Neuropsychology. Child
|
February 22, 2023
Prospective evaluation of 24-hour movement behaviors among adolescents recovering from a sport-related concussion
Riley P Brayton, August M Price, Carrie Jones, et al.
The Journal of Spinal Cord Medicine
|
June 8, 2021
Biomechanical analysis of wheelchair athletes with paraplegia during cross-training exercises
Carrie Jones, Alyssa J Schnorenberg, Kristin Garlanger, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association
|
January 15, 2008
Regression in autism: prevalence and associated factors in the CHARGE Study
Robin L Hansen, Sally Ozonoff, Paula Krakowiak, et al.
Journal of Neurophysiology
|
November 6, 2015
Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys
Annaelle Devergnas, Erdong Chen, Yuxian Ma, et al.
Journal of Medicinal Chemistry
|
May 16, 2009
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4
Linus S Lin, Thomas Lanza, James P Jewell, et al.
Journal of Medicinal Chemistry
|
September 21, 2013
Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)
Mark Turlington, Meredith J Noetzel, Aspen Chun, et al.
Expert Opinion on Therapeutic Targets
|
November 25, 2022
Preclinical target validation for non-addictive therapeutics development for pain
Richard Hargreaves, Karen Akinsanya, Seena K Ajit, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Papua and New Guinea Medical Journal
|
November 11, 2010
Is a 'convenience' sample useful for estimating immunization coverage in a small population?
Jean E Weir, Carrie Jones
ACS Chemical Biology
|
January 25, 2007
Preclinical drug discovery research and training at Vanderbilt
Craig W Lindsley, David Weaver, Carrie Jones, et al.
The International Journal on Drug Policy
|
May 31, 2021
Appreciating contributions more than celebrating resilience: Reflections on the disclosure of substance use in Appalachia
Lindy Clapp, Samuel Conner, David Fonseca, et al.
Applied Neuropsychology. Child
|
February 22, 2023
Prospective evaluation of 24-hour movement behaviors among adolescents recovering from a sport-related concussion
Riley P Brayton, August M Price, Carrie Jones, et al.
The Journal of Spinal Cord Medicine
|
June 8, 2021
Biomechanical analysis of wheelchair athletes with paraplegia during cross-training exercises
Carrie Jones, Alyssa J Schnorenberg, Kristin Garlanger, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association
|
January 15, 2008
Regression in autism: prevalence and associated factors in the CHARGE Study
Robin L Hansen, Sally Ozonoff, Paula Krakowiak, et al.
Journal of Neurophysiology
|
November 6, 2015
Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys
Annaelle Devergnas, Erdong Chen, Yuxian Ma, et al.
Journal of Medicinal Chemistry
|
May 16, 2009
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4
Linus S Lin, Thomas Lanza, James P Jewell, et al.
Journal of Medicinal Chemistry
|
September 21, 2013
Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)
Mark Turlington, Meredith J Noetzel, Aspen Chun, et al.
Expert Opinion on Therapeutic Targets
|
November 25, 2022
Preclinical target validation for non-addictive therapeutics development for pain
Richard Hargreaves, Karen Akinsanya, Seena K Ajit, et al.
Page
of 2